Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / REPROCELL
Company

REPROCELL

Tracked across 1 events · 8 articles · First seen Mar 03, 2026 · Last active Mar 03, 2026

Sentiment
70
Attention
4
Events
1
Relationships
3
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 70
Tech
REPROCELL Launches GMP iPSC Manufacturing Service
REPROCELL launched its US FDA compliant Good Manufacturing Practice (GMP) Master Cell Bank (MCB) manufacturing service for human induced pluripotent stem cells (iPSCs). This integrated service aims to accelerate IND submissions for cell therapy developers, enhancing REPROCELL's market position and revenue potential.
Mar 03, 2026 · 8 articles
Relationships (3)
Chikafumi Yokoyama CEO ↔ REPROCELL Chikafumi Yokoyama is the CEO of REPROCELL Inc.
Histocell partner ↔ REPROCELL REPROCELL partners with Histocell for European MCB/WCB manufacturing.
Maryland Stem Cell Research Fund grant provider ↔ REPROCELL Maryland Stem Cell Research Fund provided a commercialization grant to REPROCELL
NEWSDESK
Track REPROCELL live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.